The metabolic breakdown of pharmaceuticals by living organisms, often mediated by specialised enzyme systems, is known as drug metabolism. More specifically, xenobiotic metabolism refers to the set of metabolic pathways that alter the chemical structure of xenobiotics, which are substances foreign to an individual's normal biochemistry, like any drug or poison. The term comes from the Greek words xenos, meaning "stranger," and biotic, meaning "related to living beings." These bio transformational routes, which are found in all significant groupings of species, are thought to have existed long ago. These processes frequently cleanse harmful substances (although in some cases the intermediates in xenobiotic metabolism can themselves cause toxic effects). The field of pharmacokinetics investigates how drugs are metabolised. An essential component of pharmacology and medicine is the metabolism of pharmacological medicines. For instance, a drug's pharmacologic action's duration and potency are determined by its rate of metabolism. Multidrug resistance in infectious illnesses and cancer treatment are also influenced by drug metabolism, and dangerous drug interactions are frequently caused by the activities of certain medications as substrates or inhibitors of enzymes involved in xenobiotic metabolism. The xenobiotic metabolism of microorganisms determines whether a contaminant will be broken down during bioremediation or stay in the environment, making these pathways crucial in environmental research. In agriculture, the xenobiotic metabolism enzymes, in particular the glutathione S-transferases, are crucial because they may result in pesticide and herbicide resistance.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand